drugset / Trial / NCT00239889

Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women

NCT00239889

Phase 4 Completed 300 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

Calcitonin has been used for many years for treating osteoporosis in postmenopausal women, and it has been shown that calcitonin reduces pain after spine and hip fracture in women with osteoporosis. Therefore, this study assesses the safety and efficacy of salmon calcitonin nasal spray on muscle strength after a forearm fracture, pain, quality of life and fracture healing in postmenopausal women.

Timeline

Start
2002-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject salmon calcitonin Unknown Intranasal

Indications

No indication recorded.